Rosiglitazone Protects Endothelial Cells From Irradiation-Induced Mitochondrial Dysfunction

BACKGROUND AND PURPOSE: Up to 50–60% of all cancer patients receive radiotherapy as part of their treatment strategy. However, the mechanisms accounting for increased vascular risks after irradiation are not completely understood. Mitochondrial dysfunction has been identified as a potential cause of...

Descripción completa

Detalles Bibliográficos
Autores principales: Baselet, Bjorn, Driesen, Ronald B., Coninx, Emma, Belmans, Niels, Sieprath, Tom, Lambrichts, Ivo, De Vos, Winnok H., Baatout, Sarah, Sonveaux, Pierre, Aerts, An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082323/
https://www.ncbi.nlm.nih.gov/pubmed/32231569
http://dx.doi.org/10.3389/fphar.2020.00268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082323/
https://www.ncbi.nlm.nih.gov/pubmed/32231569
http://dx.doi.org/10.3389/fphar.2020.00268

Ejemplares similares